Intervention Protocol

Adrenocorticotropic hormone for acute gout

  1. David R Chen2,
  2. Elizabeth Tanjong Ghogomu3,
  3. Naomi Schlesinger1,*

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 7 OCT 2009

DOI: 10.1002/14651858.CD008119

Database Title

Additional Information

How to Cite

Chen DR, Tanjong Ghogomu E, Schlesinger N. Adrenocorticotropic hormone for acute gout (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008119. DOI: 10.1002/14651858.CD008119.

Author Information

  1. 1

    UMDNJ - Robert Wood Johnson Medical School, Division of Rheumatology, New Brunswick, NJ, USA

  2. 2

    UMDNJ Robert Wood Johnson Medical School, Internal Medicine, New Brunswick, New Jersey, USA

  3. 3

    University of Ottawa, Centre for Global Health, Institute of Population Health, Ottawa, Ontario, Canada

*Naomi Schlesinger, Division of Rheumatology, UMDNJ - Robert Wood Johnson Medical School, MEB 474, New Brunswick, NJ, 08903-0019, USA. schlesna@UMDNJ.EDU.

Publication History

  1. Publication Status: New
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (129K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The aim of this review is to evaluate the evidence for the efficacy and safety of ACTH, for relief of the signs and symptoms of acute gouty arthritis, compared to placebo and other treatment interventions.

View Full Article (HTML) Full (129K)